Boxer Capital Management’s Q32 Bio QTTB Stock Holding History
Bought
Maintained
Sold
Other funds holding QTTB
OM
Boxer Capital Management's QTTB Position: Q3 2026 in Review
Boxer Capital Management reduced its Q32 Bio (QTTB) stake by 18% in Q3 2026, selling an estimated $7.92M and leaving 2,577,642 shares worth $21.3M. The position accounts for 1.85% of the portfolio, ranked #17.
Boxer Capital Management first reported a position in QTTB in Q2 2026 and has held it in 2 quarters since. The position peaked at $40.1M in Q2 2026. 106 funds tracked by Wall St. Rank hold QTTB as of Q3 2026.
- Boxer Capital Management held 2,577,642 shares of Q32 Bio worth $21.3M as of Q3 2026.
- Boxer Capital Management sold 571,668 Q32 Bio shares in Q3 2026, an estimated $7.92M.
- Q32 Bio made up 1.85% of Boxer Capital Management's portfolio in Q3 2026, its #17 holding.
- Boxer Capital Management first reported a position in Q32 Bio in Q2 2026 and has held it in 2 quarters since.
- Boxer Capital Management's Q32 Bio position peaked at $40.1M in Q2 2026.
- 106 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2026.
Based on Boxer Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.